Page last updated: 2024-09-03

marimastat and Asthma

marimastat has been researched along with Asthma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashton, AW; Becker, T; Burgess, JK; Harkness, LM; Kopp, M; Weckmann, M1
Bruce, C; Thomas, PS1
Bruce, CT; Thomas, PS1

Trials

1 trial(s) available for marimastat and Asthma

ArticleYear
The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity.
    Toxicology and applied pharmacology, 2005, Jun-01, Volume: 205, Issue:2

    Topics: Adult; Antigens, Dermatophagoides; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstriction; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydroxamic Acids; Male; Metalloproteases; Methacholine Chloride; Middle Aged; Pilot Projects; Tumor Necrosis Factor-alpha

2005

Other Studies

2 other study(ies) available for marimastat and Asthma

ArticleYear
Tumstatin regulates the angiogenic and inflammatory potential of airway smooth muscle extracellular matrix.
    Journal of cellular and molecular medicine, 2017, Volume: 21, Issue:12

    Topics: Airway Remodeling; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Autoantigens; Bronchi; Chemotaxis; Collagen Type IV; Enzyme Inhibitors; Extracellular Matrix; Gene Expression Profiling; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Hydroxamic Acids; Interleukin-8; Matrix Metalloproteinases; Myocytes, Smooth Muscle; Neutrophils

2017
TNF-alpha as a target for anti-asthma therapy.
    Clinical science (London, England : 1979), 2006, Volume: 110, Issue:2

    Topics: Asthma; Bronchial Hyperreactivity; Humans; Hydroxamic Acids; Metalloendopeptidases; Tumor Necrosis Factor-alpha

2006